Insider Trading January 23, 2026

Novanta CEO Matthijs Glastra Disposes of Shares Amid Strong Year-to-Date Gains

Recent insider sale coincides with updated financial guidance and a substantial public equity offering

By Hana Yamamoto NOVT
Novanta CEO Matthijs Glastra Disposes of Shares Amid Strong Year-to-Date Gains
NOVT

Novanta Inc.'s CEO, Matthijs Glastra, executed a significant stock sale in January 2026, disposing of 7,500 shares at $140 each, amounting to $1.05 million. This transaction occurred as the company's shares demonstrated considerable upward momentum despite trading below their 52-week peak. Concurrently, Novanta revised its earnings forecasts amid a large-scale equity offering designed to bolster its financial position.

Key Points

  • Novanta CEO Matthijs Glastra sold 7,500 shares worth $1.05 million via a pre-arranged trading plan in January 2026.
  • Novanta shares are trading near $138, underperforming slightly from their 52-week high yet showing strong year-to-date gains of 16.2%.
  • The company updated its financial guidance for Q4 and full year 2025, adjusting expectations downward slightly following a significant public offering of equity units raising approximately $550 million.

On January 21, 2026, Matthijs Glastra, the Chief Executive Officer of Novanta Inc. (NASDAQ:NOVT), sold 7,500 shares of the company’s stock at a unit price of $140. The aggregate value of this transaction totaled $1.05 million. This sale took place while Novanta’s share price hovered around $138, which is near 10% below its 52-week high mark of $153.20. Despite the recent dip from its peak, the stock has exhibited robust performance, appreciating by 16.2% since the beginning of the calendar year.

Following this share disposition, CEO Glastra's direct ownership stands at 71,367 shares. Additionally, he maintains an indirect stake of 54,382 shares through the Matthijs Glastra 2021 Irrevocable Trust. Notably, Novanta’s price-to-earnings ratio is currently 93.9, a metric that, according to InvestingPro’s valuation methodologies, suggests the stock may be somewhat overvalued relative to its intrinsic fair value.

The trade was conducted pursuant to a pre-established Rule 10b5-1 trading plan, which Glastra implemented on September 11, 2025. This arrangement is managed through a trust where the CEO's spouse serves as trustee, indicating a planned approach to insider trading compliance. Investors should be cognizant of Novanta’s stock price volatility, highlighted by a beta value of 1.6, pointing to higher synchroneity with overall market fluctuations.

Looking ahead, Novanta is scheduled to release its next earnings report on February 24, 2026. Meanwhile, recent corporate developments include a revision of the company’s financial outlook for both the fourth quarter and the full 2025 fiscal year. Specifically, non-GAAP adjusted diluted earnings per share for Q4 are now projected between $0.84 and $0.91, a slight downward adjustment from the previous estimate of $0.87 to $0.93. For the entire fiscal year 2025, the forecasted adjusted diluted EPS range has been narrowed to $3.21 to $3.28, down marginally from an earlier range of $3.24 to $3.30.

In addition to earnings guidance updates, Novanta recently announced a public offering consisting of 11 million tangible equity units, priced at $50 each. This issuance is expected to generate approximately $550 million, comprising prepaid stock purchase contracts alongside senior amortizing notes maturing in 2028. Furthermore, the company has granted underwriters a 30-day option to procure up to an additional 1.65 million units to manage any potential over-allotments. These transactions have been formally reported through filings with the Securities and Exchange Commission.

Risks

  • Novanta’s stock exhibits elevated volatility with a beta of 1.6, indicating greater sensitivity to market movements, which imposes risk for investors.
  • The company's share price is currently trading at a high P/E ratio of 93.9, implying potential overvaluation relative to its fair value.
  • Revised earnings guidance reflects modest downward adjustments, signaling potential challenges in meeting previously anticipated financial targets.

More from Insider Trading

Giftify VP Executes Monthly 10b5-1 Sale, Disposes of 1,000 Shares for $1,050 Feb 2, 2026 Renasant CFO Disposes of $472,932 in Shares; Company Posts Q4 Beat Feb 2, 2026 First Community Bankshares CRO Derek Bonnett Buys $17,499 in Stock as Company Announces Results and Strategic Moves Feb 2, 2026 Principal Financial CEO Disposes of $697,300 in Stock; JPMorgan Lowers Rating to Neutral Feb 2, 2026 Waste Management COO Executes Stock Transactions to Cover Tax Liability; Company Near Fair Value Feb 2, 2026